Periorbital myxedema treated with intralesional hyaluronidase

PURPOSE: Periorbital myxedema is one the most challenging symptoms for patients with Graves' eye disease (GED). The treatment of this condition is complex and often unsatisfactory. This case demonstrates the use of intralesional hyaluronidase to treat cosmetically concerning periorbital myxedem...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindgren, Aleksandra L., Sidhu, Sharleen, Welsh, Kathleen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262547/
https://www.ncbi.nlm.nih.gov/pubmed/32490285
http://dx.doi.org/10.1016/j.ajoc.2020.100751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262547/
https://www.ncbi.nlm.nih.gov/pubmed/32490285
http://dx.doi.org/10.1016/j.ajoc.2020.100751

Ejemplares similares